查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
採血市場增長、趨勢、COVID-19 的影響和預測 (2023-2028)
市場調查報告書
商品編碼
1190108

採血市場增長、趨勢、COVID-19 的影響和預測 (2023-2028)

Blood Collection Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 125 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在 2022 年至 2027 年的預測期內，採血市場預計將以 6.2% 的複合年增長率增長。

預計 COVID-19 在世界範圍內的爆發將對市場產生積極影響，因為血液檢測涉及檢測不同的血液樣本，以幫助診斷 COVID-19 等傳染病。預計。 測試仍然是控制 COVID-19 流行病的重要步驟。 隨著全球 COVID-19 病例數量的增加，世界各國政府正在探索允許私人實驗室加強血液檢測的可能性。 此外，病毒爆發已經耗盡了血液儲備。 許多因 COVID-19 而住院的免疫功能低下者需要輸血或血漿。 此外，許多政府正在採取措施幫助增加獻血量。 例如，2020 年 6 月，印度馬哈拉施特拉邦政府通過社交媒體舉措增加了獻血量。 這是為應對該地區血液短缺問題而採取的措施。 此類項目在大流行期間對許多地區的全球採血市場的增長產生了積極影響。

推動市場增長的具體因素包括對慢性病早期診斷的需求增加、外傷和事故發生率增加以及全球外科手術數量激增。

此外，由於血液病、腎髒病、代謝病、神經病等各種疾病患者的增多，採血需求也很大。 英國血栓形成、淋巴瘤、骨髓瘤和骨髓增生異常綜合徵 (MDS) 等癌症會影響骨髓、血細胞、淋巴結和淋巴系統的其他部分。 已經證實單採血液分離技術用於減少白細胞計數，直到它們可以用其他藥物控制。 根據英國貧血和淋巴瘤協會 (LLS) 2021 年情況說明書，美國大約每 3 分鐘就有 1 人被診斷出患有血癌。 此外，同樣的數據表明，2021 年美國將有 186,400 人被診斷患有英國貧血/淋巴瘤。 此外，美國有 825,651 人患有淋巴瘤，152,671 人患有霍奇金淋巴瘤，672,980 人患有非霍奇金淋巴瘤。

此外，事故數量的增加也在推動市場的增長。 根據世界衛生組織 (WHO) 的數據，到 2020 年，道路交通事故每年將導致 135 萬人死亡，20-5000 萬人將遭受非致命傷害。 事故的增加推動了對血液製品的需求，推動了市場的增長。

在預測期內，患有這些疾病和病症的患者數量穩步增加以及事故數量增加可能會提振血液採樣市場。 然而，血液污染、其他並發症和採血過程中的傷害是研究市場的主要限制因素。

主要市場趨勢

針頭和注射器有望佔據重要的市場份額

要快速檢測 COVID-19 病例，就需要廣泛使用診斷方法來遏制病毒的快速傳播。 決定了公共衛生緊急情況，授權緊急使用體外診斷 (IVD) 來診斷 COVID-19，並最終在世界範圍內推動血液檢測。稻田。 因此，預計針頭和注射器部分在預測期內將呈現健康增長。 使用皮下注射針頭和注射器是最常用的採血方法。 因此，採血針頭和注射器因其在世界範圍內的廣泛使用而有望主導市場。

除了大流行之外，許多其他傳染病也在流行，增加了對診斷性血液樣本採集的需求，進而推動了對採血針頭和注射器的需求。 例如，題為“The Order of Draw during Blood Collection”的研究題為“The Order of Draw during Blood Collection”。 A Systematic Literature Review”（發表於 MDPI Journal，2021 年 2 月）將帶有針頭的注射器列為常見的開放式採血系統。 注射器是抽血師採血工具包的重要組成部分。 因此，在預測期內，前部採血對注射器和針頭的需求推動了該部門的增長。

此外，醫療器械領域的各種進步也在推動市場增長。 例如，根據 2020 年 9 月在 Hindwi Journal 上發表的題為“Variation of the Penetration Effort in an Artificial Tissue by Hypodermic Needles”的研究，現在在多種情況下使用矽化針頭來最大限度地減少創傷，並使用短斜角來最大限度地減少風險靜脈交叉穿孔。 在從靜脈中取出侵入性裝置後的幾秒鐘內會發生大量傷害，因此大多數市售針頭可在穿刺部位提供即時保護。 因此，該行業有望在預測期內保持其在全球市場的主導地位。

北美主導市場，預計在預測期內也會如此

由於對採血用品的需求不斷增加，北美的份額最大。 交通事故的增加和慢性病患病率的上升是推動所研究市場增長的主要因素。 COVID-19 對美國的影響最大，預計在預測期內市場將強勁增長。

根據美國紅十字會對 2021 年的最新估計，美國每天需要大約 36,000 個單位的紅細胞，每年大約需要輸注 2100 萬份血液成分。 此外，根據 Globocan 2020 報告，加拿大到 2020 年將有 8,506 例非霍奇金淋巴瘤病例和 313 例死亡病例。 預計非霍奇金淋巴瘤病例數量的增加將提振血液採集市場的需求。

然而，國內主要市場參與者贏得的各種策略預示著市場的增長。 例如，2021 年 12 月，獲得美國病理學家協會認可並被公認為診斷測試服務領導者的 Ethos Laboratories 將推出 Tru-Immune，這是一種用於 COVID-19 中和抗體測試的指尖自採試劑盒。

此外，在 2021 年 12 月，我們收購了一家簡單的採血設備製造商 Tasso。 在 2020 年年中籌集 1700 萬美元啟動運營後，該公司又籌集了 1 億美元用於擴大先進家用採血設備的生產和商業部署。 越來越多的慢性病和與生活方式有關的疾病需要採血進行診斷，從而促進了該地區的市場增長。

競爭格局

採血市場競爭激烈，由幾家大型企業組成。 Becton、Dickinson and Company、Cardinal Health、F.L. Medical SRL、Greiner Bio-One International GmbH、Haemonetics Corporation、Henry Schein Inc、McKesson Corporation、Medline Industries Inc、PreQ Systems 和 Qiagen 等公司佔據了很大的市場份額。 .

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 對慢性病早期診斷的需求不斷增長
    • 受傷和事故發生率增加
    • 全球外科手術數量增加
  • 市場製約因素
    • 血液污染和其他並發症
    • 採血過程中受傷
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（市場規模/貨幣基礎）

  • 按產品分類
    • 針頭，注射器
    • 試管（血漿分離管、血清分離管等）
    • 柳葉刀
    • 血袋
    • 其他產品
  • 通過申請
    • 診斷
    • 治療
  • 最終用戶
    • 醫院和診斷中心
    • 血庫
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Becton, Dickinson and Company
    • Cardinal Health
    • Terumo Corporation
    • FRESENIUS KABI
    • Haemonetics Corporation
    • Henry Schein Inc.
    • McKesson Corporation
    • Medline Industries Inc.
    • PreQ Systems
    • Qiagen
    • Grifols
    • Smiths Medical
    • Quest Diagnostics
    • Nipro Medical Corporation

第7章 市場機會今後動向

簡介目錄
Product Code: 66769

The Blood Collection Market is expected to grow at a CAGR of 6.2% during the forecast period, 2022-2027.

The outbreak of COVID-19 worldwide is expected to positively impact the market because blood testing involves the testing of various blood samples, which helps diagnose infectious diseases such as COVID-19. Testing remains a crucial step in controlling the COVID-19 pandemic. As the number of COVID-19 cases is increasing worldwide, governments across the globe are exploring the possibilities of allowing private laboratories to ramp up blood testing. Moreover, the blood reserves have been depleting due to the virus outbreak. Many individuals with weak immune systems who have been infected by COVID-19 and are hospitalized need a blood/plasma transfusion. Many governments are also taking initiatives to help increase blood donation. For instance, in June 2020, the Maharashtra state government in India used social media initiatives to increase the number of blood donations. The move was taken following the shortage of blood in the region. Such programs have positively impacted the global blood collection market growth in many regions during the pandemic.

Specific factors driving the market growth include the rising demand for early diagnosis of chronic conditions, increasing incidence of trauma and accidents, and a surge in the number of surgical procedures carried out worldwide.

Blood collection has also witnessed a great demand due to an increased number of patients suffering from various ailments related to blood, kidney, metabolic diseases, and neurological disorders. Cancers such as Leukemia, lymphoma, myeloma, and myelodysplastic syndromes (MDS) can affect the bone marrow, blood cells, lymph nodes, and other parts of the lymphatic system. It has been observed that apheresis technology has been used to reduce the number of white cells until other medications can control them. According to the Leukemia and Lymphoma Society (LLS) Factsheet 2021, approximately every three minutes, one person in United States is diagnosed with blood cancer. Moreover, as per the same source, 186,400 people in United States will be diagnosed with Leukemia and lymphoma in 2021. In addition, 825,651 people lived with lymphoma in United States, 152,671 people resided with Hodgkin lymphoma, and 672,980 people lived with non-Hodgkin lymphoma.

Moreover, the growing number of accidents also boosts the market growth. According to the World Health Organization, 2020, 1.35 million people die yearly from road accidents, and 20-50 million suffer from non-fatal injuries. The increasing number of accidents drives the demand for blood products, boosting the market growth.

The steady increase in the number of patients suffering from these diseases and ailments and the growing number of accidents may boost the blood collection market during the forecast period. However, blood contamination, other complications, and injuries caused during the blood collection are the major restraining factor for the market studied.

Key Market Trends

Needles and Syringes are Expected to Hold a Significant Market Share

The immediate detection of COVID-19 cases requires the wide availability of diagnostics to control the virus's rapid spread. A public health emergency was determined, justifying the authorization of emergency use of in vitro diagnostics (IVDs) to diagnose COVID-19, which ultimately drives blood testing worldwide. Hence, the needles and syringes segment is expected to see healthy growth over the forecast period. Using hypodermic needles and syringes is the most common means of blood sampling. Therefore, blood collection needles and syringes are expected to dominate the market owing to their extensive use all across the globe.

Apart from the pandemic, many other infectious diseases are prevalent, increasing the demand for blood specimen collection for diagnosis, thereby boosting the demand for needles and syringes for blood collection. For instance, in the study titled "The Order of Draw during Blood Collection: A Systematic Literature Review," published in the MDPI Journal in February 2021, a syringe with a needle is a common open blood collection system. Syringes are an essential part of any phlebotomist's blood-collection device toolkit. Thus, the demand for syringes and needles in fore blood collection boosted the segment growth over the forecast period.

Various advancements in the field of medical devices are also fueling market growth. For example, According to the study titled "Variation of the Penetration Effort in an Artificial Tissue by Hypodermic Needles," published in the Hindwi Journal in September 2020, siliconized needles are currently being used in multiple instances to minimize trauma and minimize the risk of vein cross perforation with a short bevel. Because a vast number of injuries occur within seconds after an invasive device is removed from the vein, the majority of the marketed needles provide immediate protection at the puncture site. Hence, this segment is expected to retain its dominance in the global market over the forecast period.

North America Dominates the Market and is Expected to do the Same in the Forecast Period

North America holds the largest share of the market studied, which is attributed to the increasing demand for blood collection products. An increase in the number of road accidents and the rising prevalence of chronic diseases are the major factors driving the growth of the market studied. With the COVID-19 impact being the highest in United States, the region foresees good growth in the market during the forecast period.

According to the American National Red Cross, 2021 updated estimates, approximately 36,000 units of red blood cells are needed every day, and nearly 21 million blood components are transfused each year in United States. Additionally, according to the Globocan 2020 report, Canada had 8,506 cases of Non-Hodgkin lymphoma and 313 deaths caused due to it in 2020. The increase in cases of Non-Hodgkin lymphoma is expected to boost the demand for the blood collection market.

However, various strategies acquired by the key market players in the country anticipated market growth. For instance, in December 2021, Ethos Laboratories, a College of American Pathologists-accredited and certified leader in diagnostic testing services, launched Tru-Immune, a finger prick, self-collection kit for its COVID-19 neutralizing antibody test.

Additionally, in December 2021, Tasso, a maker of simplified blood collection devices. After raising only USD 17 million to begin operations in mid-2020, the company has raised USD 100 million to expand its production and commercial reach for advanced at-home blood collection devices. The growing number of chronic diseases and lifestyle-related disorders requires blood collection for their diagnosis, which boosts the region's market growth.

Competitive Landscape

The blood collection market is highly competitive and consists of several major players. Companies like Becton, Dickinson and Company, Cardinal Health, F.L. Medical SRL, Greiner Bio-One International GmbH, Haemonetics Corporation, Henry Schein Inc., McKesson Corporation, Medline Industries Inc., PreQ Systems, and Qiagen, among others, hold substantial shares in the market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Early Diagnosis of Chronic Conditions
    • 4.2.2 Increasing Incidence of Trauma and Accidents
    • 4.2.3 Surge in the Number of Surgical Procedures Carried Out Worldwide
  • 4.3 Market Restraints
    • 4.3.1 Blood Contaminations and Other Complications
    • 4.3.2 Injury Caused During Blood Collection
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value)

  • 5.1 By Product
    • 5.1.1 Needles and Syringes
    • 5.1.2 Tubes (Plasma-separating Tubes, Serum-separating Tubes, etc.)
    • 5.1.3 Lancets
    • 5.1.4 Blood Bags
    • 5.1.5 Other Products
  • 5.2 By Application
    • 5.2.1 Diagnostics
    • 5.2.2 Treatment
  • 5.3 By End User
    • 5.3.1 Hospitals and Diagnostic Centers
    • 5.3.2 Blood Banks
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Becton, Dickinson and Company
    • 6.1.2 Cardinal Health
    • 6.1.3 Terumo Corporation
    • 6.1.4 FRESENIUS KABI
    • 6.1.5 Haemonetics Corporation
    • 6.1.6 Henry Schein Inc.
    • 6.1.7 McKesson Corporation
    • 6.1.8 Medline Industries Inc.
    • 6.1.9 PreQ Systems
    • 6.1.10 Qiagen
    • 6.1.11 Grifols
    • 6.1.12 Smiths Medical
    • 6.1.13 Quest Diagnostics
    • 6.1.14 Nipro Medical Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS